Rankings
▼
Calendar
SRPT Q2 2017 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
Q2 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$35M
Gross Profit
$34M
98.5% margin
Operating Income
-$63M
-180.9% margin
Net Income
-$63M
-180.1% margin
EPS (Diluted)
$-1.15
QoQ Revenue Growth
+114.2%
Cash Flow
Operating Cash Flow
-$85M
Free Cash Flow
-$88M
Stock-Based Comp.
$10M
Balance Sheet
Total Assets
$450M
Total Liabilities
$72M
Stockholders' Equity
$378M
Cash & Equivalents
$168M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$35M
$0
—
Gross Profit
$34M
-$44M
+178.6%
Operating Income
-$63M
-$62M
-2.0%
Net Income
-$63M
-$62M
-1.2%
← FY 2017
All Quarters
Q3 2017 →